Matthew Stanton
Stock Analyst at Jefferies
(0.19)
# 3,661
Out of 4,667 analysts
5
Total ratings
33.33%
Success rate
-31.07%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $6.57 | +21.77% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.61 | +101.86% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $25.01 | -12.04% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $44.65 | +43.34% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $6.57
Upside: +21.77%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.61
Upside: +101.86%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $25.01
Upside: -12.04%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $44.65
Upside: +43.34%